The CIM Courses system will be down temporarily undergoing routine maintenance.
Apr 11, 2016 by joelt
PUBH 6374 : Pharmaceutical Policy
Mon, 11 Apr 2016 09:02:31 GMT
Fri, 25 Mar 2016 15:09:15 GMT
Catalog Pages referencing this course
Prevention and Community Health
Public Health (PUBH)
Programs referencing this course
HA-MHA: Health Administration
PPAHP-PHD: Public Policy and Administration, Health Policy Track
Milken Institute School of Public Health
Public Health (PUBH)
Long Course Title
Short Course Title
Number of Credits
Default Grading Method
Repeatable for Credit?
Frequency of Offering
Are there Course Equivalents?
Are Fees Applicable?
Explanation and Description of Fees
Are Additional Resources Required?
Explanation of Additional Resources
Justification for Additional Resources
Describe any Sources of Additional Funding
Legal and regulatory frameworks related to the demand for and supply / quality of pharmaceutical products. Policies specific to drug development, pricing, reimbursement, use, dissemination of information, and post-marketing surveillance.
By the end of this course students will have an understanding of: 1. Basic concepts in pharmaceutical policy and the nature of the pharmaceuticals market. 2. The stages of drug development, and the lifecycle of a medicine 3. The history, ethos, scope, and current challenges surrounding the regulation of medicines. 4. The fundamentals of pharmaceutical intellectual property protection and the implications of this for pharmaceutical R&D, regulation, financing, pricing and access to medicines 5. State and federal programs and private sector approaches to prescription drug financing and coverage. 6. Issues in advertising and promotion of prescription and over-the-counter drugs, and of industry-provider relationships 7. An overview of CER and HTA and their application to pharmaceutical policy decision-making 8. Key differences between pharmaceutical policies in the US and other major industrialized nations. 9. Challenges and opportunities in the provision of access to medicines around the world. 10. An overview of key challenges in pharmaceutical policy. 11. How to critically appraise pharmaceutical policies and develop policy options for improving these.
Uploaded a Course Syllabus
Pharmaceutical Policy Syllabus PubH 6374.docx
Explanation of how the course differs from similar GW courses
Course Reviewer Comments
Mon, 12 Jan 2015 16:05:27 GMT